Skip to content

The Effect of aerobic exercise on hepatotoxicity induced by intratracheal instillation of iron oxide nanoparticles in wistar rats

The Effect of aerobic exercise on hepatic enzymes and tissue after the intratracheal instillation of iron oxide nanoparticles in wistar rats

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014021816624N1
Enrollment
48
Registered
2014-03-25
Start date
2014-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatotoxicity. Hepatic failure (acute)(chronic) due to drugs

Interventions

Intervention 1: Experimental 3(aerobic exercise, nanoparticles & anesthesia): in this group, at first rats ran on a treadmill then anesthetized and iron oxide nanoparticles were injected into their tr
Treatment - Drugs
Diagnosis
Experimental 3(aerobic exercise, nanoparticles & anesthesia): in this group, at first rats ran on a treadmill then anesthetized and iron oxide nanoparticles were injected into their trachea. Aerobic e
Experimental group (1)(aerobic exercise): in this group male wistar rats were trained to do low-intensity aerobic exercise. With an intensity of approximately 35% to 40% VO2max, they ran on a motor-dr
Experimental 2(nanoparticle, anesthesia): as concerns intratracheal instillation for every injection, a 0.1ml dose of 100mg/ml distilled water and IONPs suspension solution has been injected into the
Control group: this group did not receive any intervention and were weighed every day.
Placebo 4(distillated water, anesthesia): as concerns intratracheal instillation for every injection, a 0.1ml distilled water has been injected into the rat's thetrachea. Administration repeated 7 ti
Placebo 5(aerobic exercise, anesthetists): at first rats ran on a treadmill then anesthetized and weighed. Rats were trained to do low-intensity aerobic exercise. With an intensity of approximately 35

Sponsors

vice chancellor for research, Islamic Azad University Isfahan(Khorasgan)Branch
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
1 Years to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: public health; physical ability; normal limbs Exclusion criteria: physical disability.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
ALT. Timepoint: 14 days after the intervention. Method of measurement: Enzyme units per liter.;AST. Timepoint: 14 days after the intervention. Method of measurement: Enzyme units per liter.;ALP. Timepoint: 14 days after the intervention. Method of measurement: Enzyme units per liter.

Secondary

MeasureTime frame
Hepatic tissue sections. Timepoint: 14 days after the intervention. Method of measurement: Observed slides hepatic tissues sections.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Gholamreza Sharifi

Islamic Azad University Isfahan(Khorasgan) Branch

gre_sharifi@yahoo.com+98 31 1535 4135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026